Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap44.2B
Enterprise Value43.2B
P/E Ratio23.29
PEG Ratio-1.89
Price/Sales Ratio8.23
Price/Book Ratio3.97
Enterprise/Revenue7.91
Enterprise/EBITDA18.17

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.35
Operating Margin0.41
AD

Management Effectiveness

Return On Assets0.16
Return On Equity0.18

Income Statement

Revenue4.58B
Revenue/Share5.83
Gross Profit3.17B
EBITDA2.06B
Net Income1.62B
Diluted EPS2.06

Balance Sheet

Total Cash2.42B
Total Cash/Share3.08
Total Debt3.72M
Total Debt/Equity0
Current Ratio10.54
Book Value Per Share12.07

Price History

52-Week Change-13.13
52-Week High71.51
52-Week Low37.5
Moving Average 50 Days44.64
Moving Average 200 Days52.17

Statistics

Average Volume7.43M
Shares Outstanding785.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.2
Trailing Annual Dividend Yield2.5
Payout Ratio0.63
Last Split Factor19:10
Last Split DateMay 21, 2021
AD